Crucially, there was reportedly no pharmacovigilance system in place to monitor or respond to adverse drug reactions, despite SAHPRA noting "reports of adverse events, including hospitalisations, linked to the use of these products." All GIP/GLP-1 injectable products found on the site were seized, and iDexis was instructed to initiate a full recall of affected products distributed through healthcare providers, pharmacies, and other channels
Unlimited clinician messaging
ngi trng thnh khe mnh, c th thng c kh nng t tng hp L-Carnitine p ng nhu cu hng ngy, v vy nu cn b sung L-Carnitine bn cn tham kho kin bc s cng nh chuyn gia dinh dng trnh nh hng n sc khe
(NYSE: HIMS) got slapped with a securities fraud class action lawsuit
V th, trc khi s dng, bn nn cn nhc k lng v tham kho kin chuyn gia m bo t hiu qu lm sng da tt nht v an ton khi s dng